The longtime head of Novo Nordisk’s China business will leave the company, the Danish drugmaker said on Friday, as it competes against Eli Lilly and a growing number of local drugmakers in the world’s second largest pharmaceutical market.
BEIJING, Jan 30 (Reuters) – The longtime head of Novo Nordisk’s (NOVOb.CO), opens new tab China business will leave the company, the Danish drugmaker said on Friday, as it competes against Eli Lilly (LLY.N), opens new tab and a growing number of loca… [1058 chars]
Source: Reuters | Published: 2026-01-30T08:48:10Z
Credit: Reuters
